AliveCor Consumer ECG Now Spots Bradycardia, Tachycardia, and AFib

AliveCor, the company that introduced practical and useful consumer ECG devices to the market, just got FDA clearance for its KardiaMobile monitor to detect bradycardia and tachycardia. The device has already been cleared to help identify the existence of atrial fibrillation (AFib), but now it can spot abnormally slow or fast heart rhythms.

So far, KardiaMobile is the only consumer device with such a set of indications, allowing it to uncover a lot more pathologies than other available ECGs.

The device identifies heart rhythms between 40 and 50 beats for minute, being bradycardia, and between 100 and 140 beats for minute, which is tachycardia. Because these conditions often come without any obvious symptoms, detecting them during the course of one’s day can go a long way to helping to prevent serious health issues.

“No other consumer ECG device in the world, can tell you more about your heart than KardiaMobile,” in a statement said AliveCor Chief Executive Officer, Ira Bahr. “Until today, patients have been frustrated when devices label their ECG reading as ‘unclassified’ or ‘inconclusive.’ Starting today, KardiaMobile is the first personal ECG device that can begin to materially reduce the number of those determinations. Critically, KardiaMobile is also the only personal ECG that can detect Atrial Fibrillation at heart rates above 120, and heart rates below 40.”